Industry-Supported Symposia

Industry-Supported Symposia are approved by the Program Committee as independent activities held in conjunction with iMig 2018. Topics are intended to complement the Plenary Sessions as well as the Mini Symposia of the Conference. Industry-Supported Symposia are sponsored by a variety of companies and offered to Conference attendees free of charge.

Thursday, May 3, 2018

12:45 – 13:45

Symposium supported by Merck: Systemic Therapy of Malignant Pleural Mesothelioma: First-line and Beyond
Room: Confederation I – Level 4
Chair: Dr. Quincy Chu, Cross Cancer Institute, Canada

  • 12:45 – 12:50: Introduction and Audience Poll – Dr. Quincy Chu
  • 12:50 – 13:20: Debate – There are NO True Second-Line Systemic Treatment Options for Malignant Pleural Mesothelioma – PRO: Dr. Paul Wheatley-Price; CON: Dr. Penelope Bradbury
  • 13:20 – 13:25: Final Audience Poll – Dr. Quincy Chu
  • 13:25 – 13:40: What are the First-Line Systemic Treatment Options for Malignant Pleural Mesothelioma? – Dr. Penelope Bradbury
  • 13:40 – 13:45 PM: Discussion/Questions – Dr. Paul Wheatley-Price and Dr. Penelope Bradbury

Conference Newsletter

Close

Subscribe to the Newsletter to receive important information about the upcoming Conference.